EUVIMEDEUVIMED entdecken
Open Access

Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study

Behnood Bikdeli iD, Ying-Chih Lo, Candrika D Khairani, Antoine Bejjani, David Jimenez iD, Stefano Barco iD, Shiwani Mahajan, César Caraballo, Eric A Secemsky, Frederikus A Klok, Andetta R Hunsaker, Ayaz Aghayev und 13 weitere

Thrombosis and Haemostasis · 01.06.2023 · 123 (06) · 649-662

DOI: 10.1055/a-2039-3222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.06.2023. Verfasst von Behnood Bikdeli und 24 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States. Hauptthemen laut MEDLINE: Pulmonary Embolism. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association-American Stroke Association, NHLBI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Contemporary pulmonary embolism (PE) research, in many cases, relies on data from electronic health records (EHRs) and administrative databases that use International Classification of Diseases (ICD) codes. Natural language processing (NLP) tools can be used for automated chart review and patient identification. However, there remains uncertainty with the validity of ICD-10 codes or NLP algorithms for patient identification.

Methods

The PE-EHR+ study has been designed to validate ICD-10 codes as Principal Discharge Diagnosis, or Secondary Discharge Diagnoses, as well as NLP tools set out in prior studies to identify patients with PE within EHRs. Manual chart review by two independent abstractors by predefined criteria will be the reference standard. Sensitivity, specificity, and positive and negative predictive values will be determined. We will assess the discriminatory function of code subgroups for intermediate- and high-risk PE. In addition, accuracy of NLP algorithms to identify PE from radiology reports will be assessed.

Results

A total of 1,734 patients from the Mass General Brigham health system have been identified. These include 578 with ICD-10 Principal Discharge Diagnosis codes for PE, 578 with codes in the secondary position, and 578 without PE codes during the index hospitalization. Patients within each group were selected randomly from the entire pool of patients at the Mass General Brigham health system. A smaller subset of patients will also be identified from the Yale-New Haven Health System. Data validation and analyses will be forthcoming.

Conclusions

The PE-EHR+ study will help validate efficient tools for identification of patients with PE in EHRs, improving the reliability of efficient observational studies or randomized trials of patients with PE using electronic databases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary EmbolismHumansReproducibility of ResultsElectronic Health RecordsPredictive Value of TestsInternational Classification of DiseasesAlgorithms

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Thrombosis Research Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • YNHH/Yale Center for Outcomes Research and Evaluation (CORE), New Haven, Connecticut, United States.
  • Cardiovascular Research Foundation (CRF), New York, New York, United States.
  • Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
  • Respiratory Department, Hospital Ramón y Cajal and Medicine Department, Universidad de Alcalá (Instituto de Ramón y Cajal de Investigación Sanitaria), Centro de Investigación Biomédica en Red de Enfermedades Respiratori…

ORCID-Profile: Behnood Bikdeli, David Jimenez, Stefano Barco

Förderung

  • American Heart Association-American Stroke Association
  • NHLBI NIH HHS
  • American Heart Association

Zitieren

APA

Bikdeli, B., Lo, Y. C., Khairani, C. D., Bejjani, A., Jimenez, D., Barco, S., Mahajan, S., Caraballo, C., Secemsky, E. A., Klok, F. A., Hunsaker, A. R., Aghayev, A., Muriel, A., Wang, Y., Hussain, M. A., Appah-Sampong, A., Lu, Y., Lin, Z., Aneja, S., …, & Piazza, G. (2023). Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study. Thrombosis and Haemostasis, 123(06), 649-662. https://doi.org/10.1055/a-2039-3222

Vancouver

Bikdeli B, Lo YC, Khairani CD, Bejjani A, Jimenez D, Barco S, et al. Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study. Thrombosis and Haemostasis. 2023;123(06):649-662. doi:10.1055/a-2039-3222

BibTeX
@article{Bikdeli2023,
  author = {Bikdeli, Behnood and Lo, Ying-Chih and Khairani, Candrika D and Bejjani, Antoine and Jimenez, David and Barco, Stefano and Mahajan, Shiwani and Caraballo, César and Secemsky, Eric A and Klok, Frederikus A and Hunsaker, Andetta R and Aghayev, Ayaz and Muriel, Alfonso and Wang, Yun and Hussain, Mohamad A and Appah-Sampong, Abena and Lu, Yuan and Lin, Zhenqiu and Aneja, Sanjay and Khera, Rohan and Goldhaber, Samuel Z and Zhou, Li and Monreal, Manuel and Krumholz, Harlan M and Piazza, Gregory},
  title = {Developing Validated Tools to Identify Pulmonary Embolism in Electronic Databases: Rationale and Design of the PE-EHR+ Study},
  journal = {Thrombosis and Haemostasis},
  year = {2023},
  volume = {123},
  number = {06},
  pages = {649--662},
  doi = {10.1055/a-2039-3222}
}
Kostenlos starten →